Evidence map›Paper›PMID 42123890›Full record

SynthesisMolecules (Basel, Switzerland)2026

Meta-Analysis of Bioaccessibility of Hydrophobic Compounds in Buttermilk Matrices: A Systematic Review and Quantitative Synthesis.

Assem Sagandyk, Tamara Tultabayeva, Gulmira Zhakupova, Kadyrzhan Makangali, Aknur Muldasheva, Aruzhan Shoman, Kalamkas Dairova

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Assem SagandykDepartment of Food Production, Saken Seifullin Kazakh Agrotechnical University, Astana 010000, Kazakhstan.
Tamara TultabayevaInternational School, University of California, Davis, 1 Shields Ave, Davis, CA 95616, USA.
Gulmira ZhakupovaDepartment of Food Production, Saken Seifullin Kazakh Agrotechnical University, Astana 010000, Kazakhstan.ORCID 0000-0001-7714-4836
Kadyrzhan MakangaliDepartment of Food Production, Saken Seifullin Kazakh Agrotechnical University, Astana 010000, Kazakhstan.ORCID 0000-0003-4128-6482
Aknur MuldashevaDepartment of Food Production, Saken Seifullin Kazakh Agrotechnical University, Astana 010000, Kazakhstan.ORCID 0000-0003-0116-0260
Aruzhan ShomanScientific and Innovation Center Agro Tech, Astana IT University, Astana 010000, Kazakhstan.
Kalamkas DairovaDepartment of Food Production, Saken Seifullin Kazakh Agrotechnical University, Astana 010000, Kazakhstan.ORCID 0009-0006-4487-4625

Funding

the Ministry of Agriculture of the Republic of Kazakhstan BR24892775 « Development of technology for complex and deep processing of agricultural raw materials for food production, ensuring high quality and safety of products»
6 · The paper itself

Abstract

Hydrophobic bioactive compounds, such as curcuminoids, β-carotene and long-chain lipids, as well as amphiphilic structural lipids (milk fat globule membrane (MFGM)-associated phospholipids), often exhibit low bioaccessibility due to poor aqueous solubility and/or susceptibility to degradation, which limits their effective use in functional foods. Buttermilk, a dairy byproduct enriched with proteins, lipids and MFGM components, provides a structurally complex, amphiphilic matrix that can enhance micellar solubilization, protect hydrophobic and amphiphilic compounds during digestion and thereby modulate their potential bioavailability. This systematic review and meta-analysis, conducted and reported in accordance with the PRISMA 2020 guidelines, synthesizes quantitative data from in vitro gastrointestinal digestion studies to evaluate the impact of buttermilk and related matrices (e.g., buttermilk yogurt, ultrafiltered buttermilk, and composite nanosystems) on the bioaccessibility of hydrophobic compounds and MFGM phospholipids compared with aqueous or non-buttermilk controls. We identified a limited but growing body of in vitro evidence indicating that buttermilk-based matrices generally increase the intestinal bioaccessibility of curcuminoids, β-carotene, omega-3 fatty acids, vitamin and MFGM phospholipids relative to non-buttermilk systems, with particularly pronounced effects in structured emulsions, yogurts, ultrafiltered buttermilk and MFGM-enriched nanosystems. Rather than a single effect size, the data point to a compound- and matrix-dependent spectrum of improvements, influenced by both the chemical nature of the bioactive and the supramolecular organization of the dairy matrix. Mechanistically, the available findings support a plausible hypothesis that buttermilk enhances bioaccessibility via MFGM-mediated micellar solubilization, interfacial protection against pH- and enzyme-driven degradation and favorable lipid partitioning, although these pathways remain to be confirmed in dedicated mechanistic and in vivo studies. Methodological heterogeneity and the exclusive reliance on in vitro models are important limitations, but overall, the synthesis supports buttermilk and MFGM-rich ingredients as sustainable, food-grade carriers for lipophilic nutraceuticals and highlights the importance of dairy matrix structure in the design of functional delivery systems.

Indexed as

ButtermilkAnimalsbeta CaroteneBiological AvailabilityDigestionFatty Acids, Omega-3GlycolipidsGlycoproteinsHumansHydrophobic and Hydrophilic InteractionsLipid DropletsPhospholipidsbeta CaroteneFatty Acids, Omega-3GlycolipidsGlycoproteinsmilk fat globulePhospholipidsbioaccessibility of buttermilkhydrophobic compoundsmeta-analysismilk fat globule membrane (MFGM)

Identifiers

PMID42123890
PMCPMC13165119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.